Aster Capital Management’s Oruka Therapeutics ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-105
Closed -$10K – 1366
2026
Q2
$10K Buy
+105
New +$7K ﹤0.01% 664
2026
Q1
– Sell
-25
Closed -$758 – 1420
2025
Q4
$758 Buy
+25
New +$697 ﹤0.01% 1015
2025
Q1
– Sell
-5
Closed -$97 – 1738
2024
Q4
$97 Buy
+5
New +$122 ﹤0.01% 1071

Other funds holding ORKA

Aster Capital Management's ORKA Position: Q3 2026 in Review

Aster Capital Management sold out of Oruka Therapeutics (ORKA) in Q3 2026, closing a stake of 105 shares — an estimated $10K sold.

Aster Capital Management first reported a position in ORKA in Q4 2024 and held it in 3 quarters. The position peaked at $10K in Q2 2026. 259 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • Aster Capital Management reported no remaining Oruka Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Aster Capital Management sold 105 Oruka Therapeutics shares in Q3 2026, an estimated $10K.
  • Aster Capital Management first reported a position in Oruka Therapeutics in Q4 2024 and held it in 3 quarters.
  • Aster Capital Management's Oruka Therapeutics position peaked at $10K in Q2 2026.
  • 259 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.